The Intravitreal Autologous Platelet Concentrate Injection as an Adjunct of Vitrectomy for the Treatment of Refractory Macular Holes
NCT ID: NCT02081170
Last Updated: 2014-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
16 participants
INTERVENTIONAL
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Autologous Platelet-rich Plasma as a Treatment for Macular Holes
NCT06323902
Early Vitrectomy for Macular Tractional Maculopathy
NCT01121978
Early Vitrectomy for Impending Macular Hole
NCT01121965
Optical Coherence Tomography Angiography Characteristics of Patients With Surgically Closed Full-thickness Idiopathic Macular Holes < 600 μm With Air Versus 10% SF6 Tamponade
NCT05223205
Observation of Recovery of Foveal Cone Microstructures After Macular Hole Surgery
NCT01306487
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
autologous platelet concentrate
Autologous platelet concentrate
1. pars plana vitrectomy
2. internal limiting membrane removal
3. Fluid-air exchange
4. Intravitreal autologous platelet concentrate injection
5. Intravitreal gas (14% C3F8) injection
6. Keep prone position for 7-14 days after surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Autologous platelet concentrate
1. pars plana vitrectomy
2. internal limiting membrane removal
3. Fluid-air exchange
4. Intravitreal autologous platelet concentrate injection
5. Intravitreal gas (14% C3F8) injection
6. Keep prone position for 7-14 days after surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High myopia (spherical equivalent ≤ -6.0 Diopters)
* Large size macular hole (Diameter \> 600 microns)
* Recurred or failed macular hole from previous surgery
* Chronic macular hole (symptom duration \> 6 months)
Exclusion Criteria
* Hematologic disease
* Severe maculopathy including severe diabetic retinopathy, advanced age-related macular degeneration
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Ga Eun Cho, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Se Woong Kang, MD
Role: primary
Ga Eun Cho, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-12-066
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.